MR Solutions Brings New 3D, 1000X Magnification Imaging Modality to Preclinical Research
Summary
Guildford, United Kingdom, February 24, 2016 --( This new scanning technique will be particularly valuable to researchers tackling the complexities of translational medicine – taking science to the bedside - and drug development in diverse areas; including cancer, tissue engineering, inflammation, vascular disease and neuroscience.This new technology from Optiscan fits in with our range of scanners – powerful but accessible.” MR Solutions has over 30 years’ experience and in excess of 1000 installations across the world.MR Solutions has its global headquarters at Ashbourne House, The Guildway, Old Portsmouth Road, Guildford, Surrey GU3 1LR; tel: + 44 1483 532146; information@mrsolutions.com; www.mrsolutions.com.The Optiscan uses a fluorescence(2), confocal(3) imaging system to achieve this extraordinary level of detail imaging.This new scanning technique will be particularly valuable to researchers tackling the complexities of translational medicine – taking science to the bedside - and drug development in diverse areas; including cancer, tissue engineering, inflammation, vascular disease and neuroscience.Its scanners are renowned for their excellence in terms of superior soft tissue contrast and molecular imaging ability.MR Solutions has its global headquarters at Ashbourne House, The Guildway, Old Portsmouth Road, Guildford, Surrey GU3 1LR; tel: + 44 1483 532146; information@mrsolutions.com; www.mrsolutions.com.Notes:(1) Optiscan is an Australian company that has developed and patented miniaturised confocal microscopes, and is now a global leader in the development and application of microscopic imaging technologies for medical markets.